Valuation check: ELUT's profit margin is 1791.02%, above the Healthcare sector average of 15.58%.
Get informed when a big investor buys or sells
+ FollowAs of Mar 2026
Trailing 12 months ending Mar 2026
Elutia (ELUT) currently reports a profit margin of 1791.02% as of March 2026. That compares with -169.15% in the prior-year period — up 1158.8% year over year. That is above the Healthcare sector average of 15.58%. Use the charts on this page to explore Elutia's profit margin history and peer comparisons.
Elutia's profit margin increased from -169.15% to 1791.02% — a 1158.8% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Elutia's profit margin of 1791.02% is higher than the Healthcare sector average of 15.58%. That is roughly 11392.6% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' profit margin, but Elutia's current 1791.02% should be judged against Healthcare norms (sector average: 15.58%) and against ELUT's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current profit margin of 1791.02%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 15.58%. From there, open related valuation or income-statement pages for Elutia, and consider following ELUT for alerts when major investors trade the stock.